Ibnsina Pharma Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Mohamed Mohsen Mahgoub
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.1yrs |
| CEO ownership | 6.0% |
| Management average tenure | no data |
| Board average tenure | 6.6yrs |
Recent management updates
Recent updates
CEO
Mohamed Mohsen Mahgoub
3.1yrs
Tenure
Mr. Mohamed Mohsen Mohamed Mahgoub serves as Vice Chairman and Chief Executive Officer at Ibn Sina Pharma (S.A.E) since April 2021. He served as Executive Chairman until April 2021 and has been Director at...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & CEO | 6.6yrs | no data | 6.01% EGP 149.1m | |
| Co-CEO & Director | 6.6yrs | no data | 4.81% EGP 119.3m | |
| Co-CEO & Director | 6.6yrs | no data | 5.56% EGP 137.8m | |
| Director | 6.6yrs | no data | 2.11% EGP 52.2m | |
| Director | 6.6yrs | no data | no data | |
| Director | 6.6yrs | no data | no data | |
| Director | 6.6yrs | no data | 4.49% EGP 111.4m | |
| Non-Executive Chairman | 6.6yrs | no data | 0.15% EGP 3.7m | |
| Director | no data | no data | 4.61% EGP 114.3m | |
| Director | no data | no data | no data |
6.6yrs
Average Tenure
Experienced Board: ISPH's board of directors are considered experienced (6.6 years average tenure).